Emmanuel Aboce

Emmanuel Aboce

Auto-generated profile, based on publicly available information

Emmanuel Aboce

MBN Clinical Laboratories, Kampala, Uganda

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2022 in Science
Verified
Journal Article
Closed access
CFCarlo Fischer
Carlo Fischer
TMTongai Gibson Maponga
Tongai Gibson Maponga
AYAnges Yadouleton
Anges Yadouleton
NANuro Abílio
Nuro Abílio
EAEmmanuel Aboce
Emmanuel Aboce
JDJan-Felix Drexler
Jan-Felix Drexler
The geographic and evolutionary origins of the SARS-CoV-2 Omicron variant (BA.1), which was first detected mid-November 2021 in Southern Africa, remain unknown. We tested 13,097 COVID-19 patients sampled between mid-2021 to early 2022 from 22 African countries for BA.1 by real-time RT-PCR. By November-December 2021, BA.1 had replaced the Delta variant in all African sub-regions following a South-North gradient, with a peak Rt of 4.1. Polymerase chain reaction and near-full genome sequencing data revealed genetically diverse Omicron ancestors already existed across Africa by August 2021. Mutations, altering viral tropism, replication and immune escape, gradually accumulated in the spike gene. Omicron ancestors were therefore present in several African countries months before Omicron dominated transmission. These data also indicate that travel bans are ineffective in the face of undetected and widespread infection.